General Info
Pablo Legorreta is the CEO and Founder of Royalty Pharma. He previously worked at Lazard Freres and Co. as a VP, Mergers and Acquisitions. P…
Location: New York
Country:
Industries:
Investment Regions:
Investment Stages: late-stage
angel-individual
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Searches found multiple transactions and acquisitions by Royalty Pharma led by Pablo Legorreta with activity in 2025 (e.g., company announcements in Jan-May 2025 regarding manager acquisition and company activity) and significant transactions in late 2023; most recent confirmed activity within last 6 months (announcements in 2025). The investor (Pablo Legorreta) is therefore classified as very-active. Notable invested company/asset mentioned: Evrysdi (Roche/PTC transaction).
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Pablo Legoretta
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI